Prospective Cohort Study of Patients Intolerant to High Pressure Under Continuous Positive Airway Pressure Treated With Bilevel Positive Airway Pressure as Second-line Therapy.
Prospective Cohort Study of Patients Intolerant to High Pressure Under Continuous Positive Airway Pressure Treated With Bilevel Positive Airway Pressure as Second-line Therapy.
Prospective observational study of obstructive Sleep Apnea patients treated with Bilevel
 Positive Airway Pressure: AirCurve 10 VAutoTM
To characterize, in routine practice, non compliant patient to continuous positive airway
 pressure who can get a benefit of a bilevel positive airway pressure therapy as a second line
 treatment (Aircurve 10 VAutoTM ) To evaluate the clinical management of obstructive sleep
 apnea patients treated by Aircurve 10 VAutoTM , especially impact on compliance and residual
 apnea hypopnea Index.

 To evaluate Aircurve 10 VAutoTM benefit on quality of Life and quality of sleep
Inclusion Criteria:

 -  Adult patient

 -  Obstructive Sleep Apnea Patient previously treated by Continuous positive airway
 pressure non-compliant to therapy

 -  Patient naive of bilevel Positive Airway Pressure therapy

 Exclusion Criteria:

 -  Bilevel positive airway pressure Contraindication

 -  Severe respiratory disease diagnostic